SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021.

Hannah C Lewis Harriet Ware Mairead G Whelan Lorenzo Subissi Zihan Li Xiaomeng Ma Anthony Nardone Marta Valenciano Brianna Cheng Kim Noel Christian Cao Mercedes Yanes-Lane Belinda L Herring Ambrose Otau Talisuna Nsenga NgoyThierno BaldeDavid CliftonMaria D Van Kerkhove David L Buckeridge Niklas BobrovitzJoseph OkeibunorRahul Krishan Arora Isabel Bergerinull null

Published in: BMJ global health (2022)

We report high seroprevalence in Africa suggesting greater population exposure to SARS-CoV-2 and potential protection against COVID-19 severe disease than indicated by surveillance data. As seroprevalence was heterogeneous, targeted PHSM and vaccination strategies need to be tailored to local epidemiological situations.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
public health
electronic health record
cancer therapy
early onset
smoking cessation
risk assessment
drug delivery
case control
drug induced
artificial intelligence